A research team at the MHH is comparing changes in natural killer cells of the innate immune defense system in chronic hepatitis C sufferers as a risk factor for the later development of hepatocellular carcinoma (HCC).
Mar 7, 2024
0
0
Hepatitis E is widespread among the population worldwide. The World Health Organization estimates that around 20 million people are infected with it every year.
Jan 31, 2024
0
0
Hepatitis is inflammation in the liver caused by specific viruses. The hepatitis viruses are referred to as types A, B, C, D and E. All types affect the liver, but they differ in illness severity and prevention options.
Jan 25, 2024
0
3
A few years ago, a patient was cured of multiple myeloma after being treated for hepatitis C, astounding researchers from the group led by Joaquín Martínez, from the H12O-CNIO Hematological Tumours Clinical Research Unit, ...
Jan 19, 2024
0
98
The latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers guidance for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) in chronic ...
Dec 11, 2023
0
0
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...
Dec 4, 2023
0
53
A recent study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with ...
Nov 30, 2023
0
0
Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to ...
Nov 28, 2023
0
1
Direct-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting, the annual meeting of the American ...
Nov 21, 2023
0
0
Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...
Nov 13, 2023
0
0
